Form 4: USANA Health Sciences Director Timothy Wood Reports Stock Transactions
SEC Form 4
Director Timothy Wood reported the vesting of restricted stock units and subsequent acquisition of common stock in USANA Health Sciences.
Summary
- On April 24, 2024, Timothy E Wood, a director of USANA Health Sciences Inc., reported a transaction involving restricted stock units.
- 490 restricted stock units vested, converting into 490 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Wood directly owns 5,252 shares of USANA common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction report, so the sentiment is neutral. It reflects the standard vesting of previously granted equity.
Positives
- The vesting of restricted stock units indicates that performance milestones were likely met, which is a positive signal.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking to understand management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard vesting of equity compensation.
Key Dates
| Date | Description |
|---|---|
| July 24, 2023 | 25% of Restricted Stock Units Vest |
| October 24, 2023 | 25% of Restricted Stock Units Vest |
| January 24, 2024 | 25% of Restricted Stock Units Vest |
| April 24, 2024 | 25% of Restricted Stock Units Vest; Date of transaction |
| 04/25/2024 | Date of report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.